Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Feasibility of Autologous Bone Marrow-derived Mesenchymal Stem Cells in the Management of Fistulating Perianal Crohn's Disease

NCT06822686 is registered in ClinicalTrials.gov with Oxford University Hospitals NHS Trust as lead sponsor.

NCT NCT06822686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06822686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Feasibility of Autologous Bone Marrow-derived Mesenchymal Stem Cells in the Management of Fistulating Perianal Crohn's Disease
Lead sponsor
Oxford University Hospitals NHS Trust
Phase
Not applicable
Overall status
Withdrawn
Start date
March 1, 2025
Completion date
June 11, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, fistula in ano